Scientist - Protein BioSciences at Eli Lilly and Company

San Diego, California, United States

Apply Now

Not SpecifiedCompensation

Entry Level & New GradExperience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Bachelor’s degree with basic laboratory research experience in chemistry, biochemistry or a similar discipline
Research experience working with proteins and basic biochemistry
Understanding of antibody-antigen interactions
Strong team player with effective oral and written communication skills
Ability to work productively and collaboratively in an interdisciplinary team environment

Responsibilities

Implementing studies to elucidate antibody binding and epitopes using a variety of tools but focusing on high-throughput surface plasmon resonance (SPR)
Analyzing large datasets to assess antibody characteristics and identify promising molecules based on project goals
Synthesizing reports and clearly conveying experimental results to project teams
Embracing and celebrating diversity by using a relevant and unique background and set of experiences to provide new ideas to deliver innovative solutions to drugging novel targets

Skills

SPR

surface plasmon resonance

antibody characterization

protein biochemistry

antibody-antigen interactions

data analysis

high throughput screening

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free